As the global public health community navigates the complexities of a post-pandemic era, medical professionals continue to grapple with persistent…
Read More
TWiV 1286: Clinical update with Dr. Daniel Griffin
In the latest installment of This Week in Virology (TWiV), episode 1286, clinical expert Dr. Daniel Griffin and co-host Vincent…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
The landscape of public health policy and clinical medicine is facing unprecedented friction as scientific consensus clashes with shifting political…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In the latest installment of This Week in Virology, Episode 1290, co-hosts Dr. Daniel Griffin and Vincent Racaniello deliver a…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
Public health policy experts and virologists are expressing profound concern following the latest clinical update from This Week in Virology…
Read More
Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline
Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…
Read More
The Adult Epilepsy Market Poised for Substantial Growth Amidst Unmet Clinical Needs and Promising Pipeline Innovations
The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan)…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In his latest weekly clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, delved into a multifaceted array of critical public…
Read More
TWiV 1292: Clinical Update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) have voiced significant…
Read More
